NHIC vs HIVE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 26, 2026

NHIC

41.0
AI Score
VS
NHIC Wins

HIVE

37.0
AI Score

Investment Advisor Scores

NHIC

41score
Recommendation
HOLD

HIVE

37score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric NHIC HIVE Winner
Forward P/E 0 62.8931 Tie
PEG Ratio 0 0 Tie
Revenue Growth 0.0% 73.5% HIVE
Earnings Growth 0.0% -99.9% NHIC
Tradestie Score 41.0/100 37.0/100 NHIC
Profit Margin 0.0% -98.5% NHIC
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY NHIC

Relative Price Performance (Last 90 Days)

NHIC 1M: -18.6% · 3M: -21.7% HIVE 1M: +9.4% · 3M: -12.0%

Current Technical Phase

NHIC

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.6%), weak momentum, RSI 4

RSI (14): 3.9 · Price: $8.64

HIVE

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -2.6%) with fading momentum, RSI 46

RSI (14): 46.5 · Price: $2.98

Fundamentals Snapshot

Metric NHIC HIVE
Market Cap — —
Forward P/E 0.0 -5.8
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.7%
Gross Margin — 0.4%
Operating Margin 0.0% -0.6%
EPS 0.00 -1.39
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, NHIC is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.